PDCD1 and brain neoplasm: In brain tumor infiltrating myeloid cells the percentage of CD45+ cells that were macrophages (F4/80+/CD11b+) was significantly lower in anti-PD-1 and anti-PD-1+Poly(I:C) treated mice as compared with control mice or Poly(I:C) alone treated mice (Figure 1B).